20.07.2011 • Newsbiobutanol

Cathay Industrial Biotech Files For IPO Of Up To $200 Million

China's Cathay Industrial Biotech, the world's largest producer of biobutanol, on Tuesday filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission to raise up to $200 million in an initial public offering of American Depository Shares.

Shanghai, China-based Cathay Industrial Biotech has applied for the listing of the ADSs on the Nasdaq Global Select Market under the symbol "CBIO," the filing showed.

The company, which generated annual sales of $124.6 million in 2010, has two additional product candidates in its development pipeline: I+G, a food flavor enhancer that complements monosodium glutamate (MSG), and a bioprocess technology to produce biobutanol from cellulosic biomass feedstock. The company expects to start commercial sales of I+G by the end of the first half of 2012.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read